Reclazepam
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1,4-benzodiazepin-1-yl]-1,3-oxazol-4-one | |
| Identifiers | |
| CAS Number |
76053-16-2 |
| ATC code | none |
| PubChem | CID 3052777 |
| ChemSpider |
2314554 |
| UNII |
YJL42911RA |
| KEGG |
D05710 |
| Chemical data | |
| Formula | C18H13Cl2N3O2 |
| Molar mass | 374.221 g/mol |
| |
| |
| (verify) | |
Reclazepam[1] is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.[2]
See also
References
- ↑ US Patent 4208327
- ↑ Pscyhotropics.dk (20 January 1986). "reclazepam". Retrieved 24 August 2009.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
